Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

2.6K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental astrochemistry and machine learning unravel the formation of oxygen-bearing organic molecules in extraterrestrial ices.

Communications chemistry·2026
Same author

Organic cation-induced symmetry breaking enables efficient optoelectronic transitions in double halide perovskites.

The Journal of chemical physics·2026
Same author

Automating Computational Chemistry Workflows via OpenClaw and Domain-Specific Skills.

Journal of chemical theory and computation·2026
Same author

Discovery of Selective Inhibitors for β-Actin Polymerization as Potential Anticancer Agents <i>In Vitro</i> and <i>In Vivo</i>.

Journal of medicinal chemistry·2026
Same author

Real-time visualization of collagen assembly uncovers metastable properties in hierarchical organization.

Nature communications·2026
Same author

GMFCC-UMA: A Fragment-Based Machine Learning Framework for Scalable Ab Initio-Quality Protein Energies.

Journal of chemical theory and computation·2026

Related Experiment Video

Updated: Sep 10, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.9K

Ab Initio Accuracy Neural Network Potential for Drug-Like Molecules.

Manyi Yang1, Duo Zhang2,3, Xinyan Wang3

  • 1The Institute of Green Chemistry and Engineering, Nanjing University, Suzhou, Jiangsu 215163, China.

Research (Washington, D.C.)
|August 27, 2025
PubMed
Summary

This study introduces a new neural network potential for accurately calculating atomic interactions in drug design. This machine learning model achieves high precision, matching density functional theory, for drug-like molecules.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

492

Related Experiment Videos

Last Updated: Sep 10, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.9K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

492

Area of Science:

  • Computational Chemistry
  • Machine Learning in Drug Design
  • Materials Science

Background:

  • Accurate calculation of atomic interactions is crucial for computer-aided drug design (CADD).
  • Existing methods face challenges in balancing accuracy and computational cost.
  • Neural network potentials offer a promising avenue for improving these calculations.

Purpose of the Study:

  • To develop a robust, general-purpose neural network potential for predicting interatomic interactions.
  • To enhance the representational capacity of neural network potentials for drug-like molecules.
  • To achieve chemical precision comparable to established methods while improving efficiency.

Main Methods:

  • Development of a neural network potential based on the DPA-2 framework.
  • Utilizing advanced molecular dynamics (MD) techniques, including temperature acceleration and enhanced sampling.
  • Creation of a comprehensive dataset covering relevant configurational spaces for 8 key elements (H, C, N, O, F, S, Cl, P).

Main Results:

  • The developed neural network potential accurately replicates the interatomic potential energy surface for drug-like molecules.
  • Rigorous testing, including torsion scanning and MD simulations, validates the model's performance.
  • The model achieves chemical precision comparable to density functional theory (DFT) and surpasses semi-empirical methods.

Conclusions:

  • This work presents a significant advancement in the predictive modeling of molecular interactions.
  • The developed neural network potential offers a more accurate and cost-effective approach for CADD.
  • The model has broad applicability in drug development and other scientific fields.